Dicot Pharma’s Nomination Committee is responsible for preparing and presenting proposals to the Annual General Meeting 2026. The mission includes proposals for the Chairman of the Board, Board members, Board fees (divided between the Chairman, Board members and any committees), the Chairman of the AGM, auditors' fees and the election of auditors. The Nomination Committee's proposals are submitted in connection with the notice of the next Annual General Meeting.

The Nomination Committee has now been appointed and consists of the following three members:

  • Göran Beijer, appointed by Bertil Lindkvist
  • Tore Robertsson, representing Tor Finans AB
  • Torsten Söderberg, representing Syoto AB and own holding

Shareholders who wish to submit proposals to the Nomination Committee can do so by e-mail to [email protected]. For the Nomination Committee to be able to process proposals received in a constructive manner, these should be received by the Nomination Committee no later than December 19, 2025.

Dicot Pharma's Annual General Meeting 2025 will be held on Wednesday, May 6, 2026, at 17.00 in Uppsala.